Table S1.
The list of potentially nephrotoxic agents we used in sensitivity analysis
| Potentially nephrotoxic agents | ATC code |
|---|---|
| Antidepressants/mood stabilizers | |
| Amitriptyline | N06AA09 |
| Doxepin | Not approved in Japan |
| Fluoxetine | Not approved in Japan |
| Lithium | N05AN01 |
| Antihistamines | |
| Diphenhydramine | D04AA32 |
| Doxylamine | Not approved in Japan |
| Antimicrobials | |
| Acyclivir | D06BB03 |
| Aminoglycosides | J01G |
| Amphotericin B | A01AB04 |
| Beta-lactam | J01C, J01D |
| Foscarnet | J05AD01 |
| Ganciclovir | J05AB06 |
| Pentamidine | P01CX01 |
| Quinolones | J01M |
| Rifanpin | J04AB02 |
| Sulfonamides | J01EE01 |
| Vancomycin | A07AA09 |
| Antiretrovials | |
| Adefovir | J05AF08 |
| Cidofovir | Not approved in Japan |
| Tenofovir | J05AF07, J05AF13, J05AR03, J05AR09, J05AR17, J05AR18 |
| Indinavir | J05AE02 |
| Benzodiazepines | N05BA, N05CD, N05CF |
| Calcineurin inhibitors | |
| Cyclosporine | L04AD01 |
| Tacrolimus | L04AD02 |
| Cardiovascular agents | |
| Angiotensin-converting enzyme inhibitors | C09A, C09B |
| Angiotensin receptor blockers | C09C, C09D |
| Clopidogrel | B01AC04 |
| Ticlopidine | B01AC05 |
| Statins | C10AA, C10BA |
| Chemotherapeutics | |
| Carmustine | L01AD01 |
| Semustine | Not approved in Japan |
| Cisplatin | L01XA01 |
| Interferon-alpha | L03AB01, L03AB05, L03AB06, L03AB09, L03AB10, L03AB11, L03AB12, L03AB15 |
| Methotrexate | L04AX03 |
| Mitomycin-C | L01DC03 |
| Contrast dye | V08A |
| Diuretics | |
| Loops | C03CA |
| Thiazides | C03AA |
| Triamterene | C03DB02 |
| Proton pump inhibitors | |
| Lansoprazole | A02BC03 |
| Omeprazole | A02BC01 |
| Pantoprazole | Not approved in Japan |
| Others | |
| Allopurinol | M04AA |
| Gold therapy | M01CB |
| Haloperidol | N05AD01 |
| Pamidronate | M05BA03 |
| Phenytoin | N03AB02, N03AB52 |
| Quinine | P01BC01 |
| Zoledronate | M05BA08 |
Abbreviation: ATC, Anatomical Therapeutic Chemical.